[Ru(bpy)2(5-氰尿嘧啶)2]2+ 作为一种潜在的光激活双重作用治疗剂。
[Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
机构信息
Department of Chemistry, The Ohio State University, Columbus, Ohio 43210, United States.
出版信息
Inorg Chem. 2011 Oct 3;50(19):9213-5. doi: 10.1021/ic201615u. Epub 2011 Aug 31.
Abstract
The cation cis-Ru(bpy)(2)(5CNU)(2) (bpy = 2,2'-bipyridine; 5CNU = 5-cyanouracil) was synthesized and investigated for use as a potential light-activated dual-action therapeutic agent. The complex undergoes efficient photoinduced 5CNU ligand exchange for solvent water molecules, thus simultaneously releasing biologically active 5CNU and generating Ru(bpy)(2)(H(2)O)(2). The latter binds covalently to ds-DNA, such that photolysis results in the generation of 3 equiv of potential therapeutic agents from a single molecule.
摘要
顺式-Ru(bpy)(2)(5CNU)(2)（bpy = 2,2'-联吡啶；5CNU = 5-氰尿嘧啶）阳离子被合成并研究用作潜在的光激活双重作用治疗剂。该配合物经历高效光诱导 5CNU 配体交换为溶剂水分子，从而同时释放生物活性 5CNU 并生成Ru(bpy)(2)(H(2)O)(2)。后者与 ds-DNA 共价结合，使得光解导致从单个分子生成 3 当量的潜在治疗剂。
相似文献
1
[Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
Inorg Chem. 2011 Oct 3;50(19):9213-5. doi: 10.1021/ic201615u. Epub 2011 Aug 31.
2
Cellular toxicity induced by the photorelease of a caged bioactive molecule: design of a potential dual-action Ru(II) complex.
J Am Chem Soc. 2013 Jul 31;135(30):11274-82. doi: 10.1021/ja4045604. Epub 2013 Jul 19.
3
Substituent effect and wavelength dependence of the photoinduced Ru-O homolysis in the [Ru(bpy)2(py-SO3)](+)-type complexes.
Dalton Trans. 2016 Feb 21;45(7):2897-905. doi: 10.1039/c5dt03694a. Epub 2016 Jan 11.
4
Infrared vibrational spectroscopy of [Ru(bpy)2(bpm)]2+ and [Ru(bpy)3]2+ in the excited triplet state.
Inorg Chem. 2014 Mar 3;53(5):2481-90. doi: 10.1021/ic402474t. Epub 2014 Feb 14.
5
Photoinitiated DNA Binding by cis-[Ru(bpy)2(NH3)2]2+.
Inorg Chem. 2004 Nov 15;43(23):7260-2. doi: 10.1021/ic049075k.
6
Ruthenium nitrosyl complexes with 1,4,7-trithiacyclononane and 2,2'-bipyridine (bpy) or 2-phenylazopyridine (pap) coligands. Electronic structure and reactivity aspects.
Dalton Trans. 2011 Dec 14;40(46):12527-39. doi: 10.1039/c1dt10761e. Epub 2011 Oct 11.
7
[Ru(bpy)(3-n)(dpb)(n)](2+): unusual photophysical property and efficient DNA photocleavage activity.
Inorg Chem. 2010 Jun 7;49(11):4729-31. doi: 10.1021/ic100193w.
8
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Anticancer Agents Med Chem. 2021;21(12):1602-1611. doi: 10.2174/0929867327666201020155105.
9
Electronic structure of oxidized complexes derived from cis-[Ru(II)(bpy)2(H2O)2]2+ and its photoisomerization mechanism.
Inorg Chem. 2011 Nov 7;50(21):11134-42. doi: 10.1021/ic201686c. Epub 2011 Oct 12.
10
Synthesis and characterization of ruthenium(II)-oligopyridine-peptide conjugates. Interactions of the diasteromeres Δ- and Λ-[Ru(bpy)2(4-COY-4'-Mebpy)]Cl2 (Y=Gly-Lys(1)-Lys(2)CONH2, Lys(1)-Gly-Lys(2)CONH2, Lys(1)-Lys(2)-GlyCONH2) with the oligonucleotide d(5'-CGCGAATTCGCG-3')2.
J Inorg Biochem. 2013 Oct;127:13-23. doi: 10.1016/j.jinorgbio.2013.06.010. Epub 2013 Jun 24.
引用本文的文献
1
An Increase in the Rigidity of the Environment Favors MLCT over the MC State in [Ru(bpy)(Nicotine)](Cl): A Case Study of Photolabile Ligands.
J Phys Chem A. 2025 Jan 16;129(2):439-446. doi: 10.1021/acs.jpca.4c04914. Epub 2024 Nov 4.
2
Light Activated Release of Nitrile Ligands from -Ru(L)(PPh)(nitrile) Complexes.
ACS Omega. 2024 Jul 25;9(31):34098-34105. doi: 10.1021/acsomega.4c04917. eCollection 2024 Aug 6.
3
RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor.
J Am Chem Soc. 2024 May 15;146(19):13317-13325. doi: 10.1021/jacs.4c01720. Epub 2024 May 3.
4
Binding of Stimuli-Responsive Ruthenium Aqua Complexes with 9-Ethylguanine.
ACS Omega. 2023 Sep 26;8(40):37391-37401. doi: 10.1021/acsomega.3c05343. eCollection 2023 Oct 10.
5
Ligand Rigidity Steers the Selectivity and Efficiency of the Photosubstitution Reaction of Strained Ruthenium Polypyridyl Complexes.
J Am Chem Soc. 2023 Jun 21;145(24):13420-13434. doi: 10.1021/jacs.3c03543. Epub 2023 Jun 9.
6
Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.
Chem Sci. 2022 May 16;13(23):6899-6919. doi: 10.1039/d2sc01646j. eCollection 2022 Jun 15.
7
Trifluoromethyl substitution enhances photoinduced activity against breast cancer cells but reduces ligand exchange in Ru(ii) complex.
Chem Sci. 2021 Aug 16;12(36):12056-12067. doi: 10.1039/d1sc03213e. eCollection 2021 Sep 22.
8
The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
Molecules. 2021 Sep 18;26(18):5679. doi: 10.3390/molecules26185679.
9
Ruthenium-based PACT agents based on bisquinoline chelates: synthesis, photochemistry, and cytotoxicity.
J Biol Inorg Chem. 2021 Sep;26(6):667-674. doi: 10.1007/s00775-021-01882-8. Epub 2021 Aug 10.
10
Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review.
Pharmaceutics. 2021 Jun 13;13(6):874. doi: 10.3390/pharmaceutics13060874.
本文引用的文献
1
Metal complexes as DNA intercalators.
Acc Chem Res. 2011 May 17;44(5):349-59. doi: 10.1021/ar100140e. Epub 2011 Mar 29.
2
Redox, spectroscopic, and photophysical properties of Ru-Pt mixed-metal complexes incorporating 4,7-diphenyl-1,10-phenanthroline as efficient DNA binding and photocleaving agents.
Inorg Chem. 2011 Jan 17;50(2):463-70. doi: 10.1021/ic100958r. Epub 2010 Dec 14.
3
Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2].
Dalton Trans. 2011 Jan 7;40(1):262-8. doi: 10.1039/c0dt00546k. Epub 2010 Nov 12.
4
DNA photocleavage by an osmium(II) complex in the PDT window.
Chem Commun (Camb). 2010 Sep 28;46(36):6759-61. doi: 10.1039/c0cc02571b. Epub 2010 Aug 17.
5
A potent trans-diimine platinum anticancer complex photoactivated by visible light.
Angew Chem Int Ed Engl. 2010 Nov 15;49(47):8905-8. doi: 10.1002/anie.201003399.
6
Photophysical properties, DNA photocleavage, and photocytotoxicity of a series of dppn dirhodium(II,II) complexes.
Inorg Chem. 2010 Jun 21;49(12):5371-6. doi: 10.1021/ic100588d.
7
Efficient DNA photocleavage by [Ru(bpy)2(dppn)]2+ with visible light.
Chem Commun (Camb). 2010 Apr 14;46(14):2426-8. doi: 10.1039/b925574e. Epub 2010 Jan 27.
8
Ruthenium-based chemotherapeutics: are they ready for prime time?
Cancer Chemother Pharmacol. 2010 May;66(1):1-9. doi: 10.1007/s00280-010-1293-1. Epub 2010 Mar 6.
9
Nuclear targets of photodynamic tridentate ruthenium complexes.
Dalton Trans. 2009 Dec 28(48):10926-31. doi: 10.1039/b913959a. Epub 2009 Nov 16.
10
Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.
Dalton Trans. 2009 Dec 28(48):10690-701. doi: 10.1039/b917753a. Epub 2009 Nov 11.
Zotero 插件